01 May 2006
Interleukin-8 in the blood serum of patients with alcoholic liver disease.
Renata Swiątkowska-Stodulska, Alicja Bąkowska, Anna Drobińska-JurowieckaMed Sci Monit 2006; 12(5): CR215-220 :: ID: 450291
Abstract
Background: The influence of the immune system on the development of alcoholicliver disease has recently been the object of attention. However, the connection between alcohol consumption,altered immune response, and development of changes in the liver has not been fully explained. The aimof the present study was to evaluate serum IL-8 concentration in patients with chronic alcoholic liverdisease. Material/Methods: 85 patients with different types of ALD and 35 healthy subjects were enrolledin the study. Serum IL-8 concentration was evaluated with the ELISA immunoenzymatic method. IL-8 in livertissue was measured by the indirect immunofluorescence method. Results: There was a significant correlationbetween IL-8 concentration and AST, ALP, GGT, total bilirubin and albumin levels in blood serum. A significantlyhigher concentration of IL-8 was seen in all the groups of ALD patients. The highest values were foundin patients with chronic alcoholic hepatitis, and the lowest in those with fatty liver. Significantlyhigher values were found in patients with ascites or encephalopathy in comparison to those without anyfeatures of portal hypertension and/or insufficiency of the liver cells. A high concentration of thetested cytokine is a disadvantageous prognostic factor in patients with ALD. Conclusions: IL-8 appearsto be an important factor in liver pathology in patients with ALD, especially in the development of theinflammatory process.
Keywords: Case-Control Studies, Ascites - immunology, Enzyme-Linked Immunosorbent Assay, Fatty Liver, Alcoholic - immunology, Fluorescent Antibody Technique, Indirect, Hepatic Encephalopathy - immunology, Hepatitis, Alcoholic - immunology, Interleukin-8 - blood, Liver - immunology, Liver Cirrhosis, Alcoholic - immunology, Liver Diseases, Alcoholic - immunology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952